Retatrutide Facts to Know Right Now As of April 9, 2026, retatrutide is still in Phase 3 trials and is not FDA-approved Lilly says it is legally available only inside Lilly clinical trials It is being studied as a once-weekly shot TRIUMPH-4 reported 28.7% average weight loss at 68 weeks on 12 mg TRANSCEND-T2D-1 reported 16.8% average weight loss at 40 weeks on 12 mg in adults with type 2 diabetes In TRIUMPH-4, tingling or burning skin was reported by 20.9% of people on 12 mg Lilly says more retatrutide results are expected over the next year The tracker basics stay simple: log the dose, mark the site, track symptoms, food, water, and weight Retatrutide may still be trial-only, but the weekly routine around it is real
Your healthcare provider should tell you if you need to pinch the skin before injecting
Chen P, Wu Q, Feng J, Yan L, Sun Y, Liu S, et al
Feeling like you can conquer the world when you awaken with radiant golden skin is totally natural
Here are some weve tried: The Wahls Protocol Cooking for Life Diets like the one in this book are notoriously restrictive, which can make it tough for food to feel manageable day-to-day, especially for GLP-1 users, whose interest in food may already be waning
If you are taking a GLP-1 with a thyroid issue, pay extra attention to: Protein Intake: Both thyroid issues and rapid weight loss can lead to muscle loss
